Week In Review: A Possible Solution To US De-Listing Of China Biopharmas?

A US law demands China-based companies with US listings must have their financial reports reviewed by a US auditor. The problem is Article 177 of China's security law, which prohibits foreigners from examining the inner workings of Chinese companies.